CytoGenix Announces Acceptance for Publication by Prestigious Scientific Journal, Data Shows the Effectiveness of its Novel Anti-bacterial Agent.Business Editors/Health/Medical Writers BIOWIRE2K HOUSTON--(BUSINESS WIRE)--Nov. 13, 2003 CytoGenix, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CYGX) announced Thursday that results of research conducted by Dr. Yin Chen, Vice President of R & D, and Dr. Xin Xing Tan, Senior Scientist of CytoGenix, will be published in an upcoming issue of Biochemistry, a respected research journal. This study demonstrates that the company's proprietary ssDNA technology is effective in preventing the growth of bacteria such as the strains that cause sepsis and other potentially fatal diseases. Biochemistry, an American Chemical Society The American Chemical Society (ACS) is a learned society (professional association) based in the United States that supports scientific inquiry in the field of chemistry. Founded in 1876 at New York University, the ACS currently has over 160,000 members at all degree-levels and in journal, is dedicated to "publishing the results of original research that contribute significantly to the understanding of the mechanism of biological phenomena in terms of molecular structure and/or function. Biochemistry investigates the rapidly changing arena where chemistry, biochemistry and molecular and cell biology Cell biology The study of the activities, functions, properties, and structures of cells. Cells were discovered in the middle of the seventeenth century after the microscope was invented. interrelate in·ter·re·late tr. & intr.v. in·ter·re·lat·ed, in·ter·re·lat·ing, in·ter·re·lates To place in or come into mutual relationship. in ." Dr. Chen and Dr. Tan's paper is titled "DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. Enzyme Generated by a Novel Single-Stranded DNA Expression Vector expression vector n. A vector, such as a plasmid, yeast, or animal virus genome, used to introduce foreign genetic material into a host cell in order to replicate and amplify the foreign DNA sequences as a recombinant molecule. Inhibits Expression of the Essential Bacterial Cell Division Gene ftsZ," and it will be published in the next few weeks. "This is the fourth scientific paper from the Company's laboratory published this year and the seventh in the past two years, a very significant achievement for any research group whether academic, government or industry. It is a strong indicator of our research productivity and the scientific community's recognition of the merit of this work," states Dr. Malcolm Skolnick, Chairman/CEO. "In an era of hundred million dollar research budgets, we continue to prove that valuable science can be produced with very modest means," adds Dr. Skolnick. CytoGenix, Inc. is a biopharmaceutical company that develops and markets innovative products and services based on its proprietary DNA expression technology. CytoGenix has products in pre-clinical development Pre-clinical development is a stage in the development of a new drug that begins before clinical trials (testing in humans) can begin, and during which important safety and pharmacology data is collected. including, anti-herpes, anti-psoriasis and anti-inflammatory topical creams. The company owns a U.S. patent for its core DNA expression technology and has 40 international or U.S. pending patent applications. SAFE HARBOR Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. : Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, risks associated with the acceptance of new products, competition, and other factors more fully detailed in the company's filings with the Securities and Exchange Commission. Additional information about CytoGenix and its technology can be found on the Web site at www.cytogenix.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion